A Facebook post in Urdu and English covers dual incretin drugs in kids older than six, including weight concerns for those with type 1 diabetes on insulin.
Recap by typeshit. Post by Facebook on Facebook.
Half of people with diabetes for 10 years or more said they were very satisfied on a GLP-1. Gen Z users were the most likely to stop and restart treatment.
64% of current users faced some negative reaction. Men, BIPOC respondents and the newly diagnosed reported it most, while 69% of boomers felt none.
The workflow uses glutathione or sulfatase triggers to target organelles and tumors in mice, and the authors say it takes 92 to 115 days to run.
A University of Pennsylvania mouse study found on-off GLP-1 use left mice 20 per cent heavier than those kept on the drug, and doctors warn human effects are unknown.
The clinic explains the investigational drug acts on GLP-1, GIP and glucagon receptors, which play roles in appetite, blood sugar and energy use.
Ashlee Amborn says she conceived a month into GLP-1 use. A review hints at a link in women with obesity and PMOS, but doctors say stop the drug before trying.
Loading…